[
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Co. stock underperforms Monday when compared to competitors despite daily gains",
    "summary": "Bristol Myers Squibb Co. stock underperforms Monday when compared to competitors despite daily gains",
    "url": "https://finnhub.io/api/news?id=889f74fd46bf6cc91749ccbce2d949303577eac8973a6743817d332828b0fd4e",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1737995820,
      "headline": "Bristol Myers Squibb Co. stock underperforms Monday when compared to competitors despite daily gains",
      "id": 132524419,
      "image": "",
      "related": "BMY",
      "source": "MarketWatch",
      "summary": "Bristol Myers Squibb Co. stock underperforms Monday when compared to competitors despite daily gains",
      "url": "https://finnhub.io/api/news?id=889f74fd46bf6cc91749ccbce2d949303577eac8973a6743817d332828b0fd4e"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Presents Results from CheckMate -8HW Analysis Evaluating Opdivo plus Yervoy Compared to Opdivo Monotherapy",
    "summary": "PRINCETON - Bristol Myers Squibb today announced results of an analysis from the three-arm Phase 3 CheckMate -8HW trial evaluating Opdivo plus Yervoy versus Opdivo monotherapy across all lines of...",
    "url": "https://finnhub.io/api/news?id=47fae75b5067e376d0476bfb605ab88fbe9f909a27db36aabf8551922dd04e01",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1737975922,
      "headline": "Bristol Myers Squibb Presents Results from CheckMate -8HW Analysis Evaluating Opdivo plus Yervoy Compared to Opdivo Monotherapy",
      "id": 132479976,
      "image": "",
      "related": "BMY",
      "source": "Finnhub",
      "summary": "PRINCETON - Bristol Myers Squibb today announced results of an analysis from the three-arm Phase 3 CheckMate -8HW trial evaluating Opdivo plus Yervoy versus Opdivo monotherapy across all lines of...",
      "url": "https://finnhub.io/api/news?id=47fae75b5067e376d0476bfb605ab88fbe9f909a27db36aabf8551922dd04e01"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers: promising results in colorectal cancer",
    "summary": "Bristol Myers Squibb announces that results from a Phase 3 trial showed that Opdivo combined with Yervoy significantly improved progression-free survival compared with Opdivo monotherapy for the...",
    "url": "https://finnhub.io/api/news?id=6cfdb7f436bdc8cecd2446fc37d23f96973c9c67b2de093b45d255dd6c9430fb",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1737958815,
      "headline": "Bristol Myers: promising results in colorectal cancer",
      "id": 132478417,
      "image": "",
      "related": "BMY",
      "source": "Finnhub",
      "summary": "Bristol Myers Squibb announces that results from a Phase 3 trial showed that Opdivo combined with Yervoy significantly improved progression-free survival compared with Opdivo monotherapy for the...",
      "url": "https://finnhub.io/api/news?id=6cfdb7f436bdc8cecd2446fc37d23f96973c9c67b2de093b45d255dd6c9430fb"
    }
  }
]